本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

麦克森药物批发

855.23
+13.141.56%
盘后856.481.25+0.15%19:54 EST
成交量:76.83万
成交额:6.55亿
市值:1,055.58亿
市盈率:26.63
高:855.58
开:846.66
低:843.02
收:842.09
52周最高:867.63
52周最低:558.13
股本:1.23亿
流通股本:1.23亿
量比:1.07
换手率:0.62%
股息:2.95
股息率:0.34%
每股收益(TTM):32.12
每股收益(LYR):25.86
净资产收益率:1401.75%
总资产收益率:4.78%
市净率:-60.70
市盈率(LYR):33.07

数据加载中...

2025/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/20

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/05/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/05/09

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

SEC问询函

Form CORRESP - Correspondence
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/05

重要事件披露

Form 8-K - Current report
2025/02/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/10

重要事件披露

Form 8-K - Current report